Nothing Special   »   [go: up one dir, main page]

ATE292453T1 - Antivirale arznei - Google Patents

Antivirale arznei

Info

Publication number
ATE292453T1
ATE292453T1 AT00984181T AT00984181T ATE292453T1 AT E292453 T1 ATE292453 T1 AT E292453T1 AT 00984181 T AT00984181 T AT 00984181T AT 00984181 T AT00984181 T AT 00984181T AT E292453 T1 ATE292453 T1 AT E292453T1
Authority
AT
Austria
Prior art keywords
antiviral drug
antiviral
disclosed
pharmaceutical composition
administering
Prior art date
Application number
AT00984181T
Other languages
English (en)
Inventor
Liang C Dong
Steven D Espinal
Patrick Wong
Paul R Magruder
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE292453T1 publication Critical patent/ATE292453T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00984181T 1999-12-09 2000-12-08 Antivirale arznei ATE292453T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16988399P 1999-12-09 1999-12-09
PCT/US2000/033542 WO2001041742A2 (en) 1999-12-09 2000-12-08 Antiviral medication

Publications (1)

Publication Number Publication Date
ATE292453T1 true ATE292453T1 (de) 2005-04-15

Family

ID=22617610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00984181T ATE292453T1 (de) 1999-12-09 2000-12-08 Antivirale arznei

Country Status (10)

Country Link
US (1) US20020071863A1 (de)
EP (1) EP1239840B1 (de)
JP (1) JP2003516345A (de)
KR (1) KR100738276B1 (de)
AT (1) ATE292453T1 (de)
AU (1) AU2084801A (de)
CA (1) CA2393601A1 (de)
DE (1) DE60019334T2 (de)
ES (1) ES2236012T3 (de)
WO (1) WO2001041742A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
JP2005527546A (ja) * 2002-03-26 2005-09-15 イースタン ヴァージニア メディカル スクール 局所用殺菌剤および避妊薬としてのスラミンおよびその誘導体
IL166023A0 (en) * 2002-06-28 2006-01-15 Alza Corp Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
CA2504038A1 (en) * 2002-10-31 2004-05-21 Alza Corporation Dosage form providing ascending release of liquid formulation
WO2005027855A2 (en) * 2003-02-21 2005-03-31 Jarrow Formulas, Inc. Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
CN1859897A (zh) * 2003-07-31 2006-11-08 阿尔扎公司 用于液态活性剂制剂控制释放的抗渗透的渗透装置和剂型
AU2004275826A1 (en) * 2003-09-26 2005-04-07 Alza Corporation OROS push-stick for controlled delivery of active agents
CA2540308C (en) 2003-09-26 2013-08-06 Alza Corporation Drug coating providing high drug loading and methods for providing the same
EP1677769A1 (de) * 2003-09-26 2006-07-12 Alza Corporation Formulierungen mit kontrollierter freisetzung mit einer aufsteigenden freisetzungsrate
US20050186273A1 (en) * 2003-09-26 2005-08-25 Si-Hong Yum Controlled release dosage form including a banded engine
EP1667653A1 (de) * 2003-09-26 2006-06-14 Alza Corporation Dosierform für die kontrollierte freisetzung einer wirkstoffformulierung
CA2540056C (en) * 2003-09-26 2015-03-24 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
EP1845968A2 (de) 2004-11-24 2007-10-24 Neuromolecular Pharmaceuticals, Inc Zusammensetzung mit einem nmda-rezeptor-antagonisten und levodopa und ihre verwendung zur behandlung von neurologischen erkrankungen
EP1874282B1 (de) * 2005-04-06 2010-09-15 Adamas Pharmaceuticals, Inc. Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen
UA97971C2 (ru) 2007-06-08 2012-04-10 Берингер Ингельхайм Интернациональ Гмбх Препарат невирапина пролонгированного высвобождения
KR101121589B1 (ko) * 2009-06-24 2012-03-06 대원제약주식회사 안정성이 향상된 무정형 아데포비어 디피복실 고체분산체 및 이의 제조방법
AU2010325960C1 (en) 2009-12-02 2015-08-06 Adamas Pharma, Llc Amantadine compositions and methods of use
RU2679448C2 (ru) * 2013-03-14 2019-02-11 Редхилл Байофарма Лтд. Твердые лекарственные формы, обладающие противорвотным действием, с замедленным высвобождением
WO2014204933A1 (en) 2013-06-17 2014-12-24 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
CN106456611B (zh) 2014-03-11 2021-07-20 红山生物医药有限公司 用于治疗恶心、呕吐或腹泻症状的恩丹西酮缓释固体制剂
AU2018320946B2 (en) 2017-08-24 2024-05-02 Adamas Pharma, Llc Amantadine compositions, preparations thereof, and methods of use

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3173876A (en) * 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (de) * 1960-11-29
US3276586A (en) * 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
US3546142A (en) * 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) * 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) * 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4207893A (en) * 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
FR2428519A1 (fr) * 1978-06-13 1980-01-11 Ameublement Ind Et Tech Bouchon pour trou de coulee de matiere expansee dans un moule
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4627850A (en) * 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
US4663148A (en) * 1984-03-21 1987-05-05 Alza Corporation Dispenser comprising telescopically engaging members
US4692326A (en) * 1984-03-21 1987-09-08 Alza Corporation Dispenser comprising inner positioned soft or hard capsule
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
US5324280A (en) 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
US5559158A (en) * 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
DE69535127T2 (de) * 1994-03-18 2007-02-15 Supernus Pharmaceuticals, Inc. Emulgierte arzneistoffabgabesysteme
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
ZA9710071B (en) * 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
ES2228141T3 (es) * 1998-11-17 2005-04-01 F. Hoffmann-La Roche Ag Procedimiento para la fabricacion de capsulas rellenadas con liquido.
DK1140012T3 (da) * 1998-12-17 2004-07-12 Alza Corp Omdannelse af væskefyldte gelatinekapsler til systemer til kontrolleret frigivelsessystemer ved flere coatinger

Also Published As

Publication number Publication date
WO2001041742A3 (en) 2002-02-14
KR100738276B1 (ko) 2007-07-12
DE60019334T2 (de) 2005-09-08
KR20020068051A (ko) 2002-08-24
EP1239840A2 (de) 2002-09-18
ES2236012T3 (es) 2005-07-16
AU2084801A (en) 2001-06-18
EP1239840B1 (de) 2005-04-06
JP2003516345A (ja) 2003-05-13
DE60019334D1 (de) 2005-05-12
WO2001041742A2 (en) 2001-06-14
US20020071863A1 (en) 2002-06-13
CA2393601A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
ATE292453T1 (de) Antivirale arznei
DE69805001D1 (de) Osmotische darreichungsform mit zwei mantelschichten
DE69940674D1 (de) Orale verabreichung von adenosin analogen
ATE356612T1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
DK1112060T3 (da) Doseringsform anvendende flydende formulering
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
HRP20010684B1 (en) Directly compressible matrix for controlled release of single daily doses of clarithromycin
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
DE50005082D1 (de) Verfahren zu Herstellung von PULVERFÖRMIGEn SOLUBILISATIONSHILFSSTOFFEn FÜR FESTE PHARMAZEUTISCHE DARREICHUNGSFORMEN
SE0001916D0 (sv) Novel formulation
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
HK1029277A1 (en) Pharmaceutical coating composition and method of use.
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
BR9710629A (pt) Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto
HUP0104941A2 (hu) Több gyógyszerformát tartalmazó bliszter

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1239840

Country of ref document: EP

REN Ceased due to non-payment of the annual fee